- Home
- MVBF vs TKNO Comparison
MVBF vs TKNO Comparison
Compare MVBF & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- TKNO
- Stock Information
- Founded
- MVBF 1997
- TKNO 1996
- Country
- MVBF United States
- TKNO United States
- Employees
- MVBF N/A
- TKNO N/A
- Industry
- MVBF Major Banks
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MVBF Finance
- TKNO Health Care
- Exchange
- MVBF Nasdaq
- TKNO Nasdaq
- Market Cap
- MVBF 282.7M
- TKNO 256.9M
- IPO Year
- MVBF N/A
- TKNO 2021
- Fundamental
- Price
- MVBF $22.97
- TKNO $4.69
- Analyst Decision
- MVBF Buy
- TKNO
- Analyst Count
- MVBF 4
- TKNO 0
- Target Price
- MVBF $24.50
- TKNO N/A
- AVG Volume (30 Days)
- MVBF 60.6K
- TKNO 325.8K
- Earning Date
- MVBF 07-28-2025
- TKNO 08-07-2025
- Dividend Yield
- MVBF 2.96%
- TKNO N/A
- EPS Growth
- MVBF N/A
- TKNO N/A
- EPS
- MVBF 1.29
- TKNO N/A
- Revenue
- MVBF $143,378,000.00
- TKNO $38,923,000.00
- Revenue This Year
- MVBF N/A
- TKNO $8.73
- Revenue Next Year
- MVBF $14.75
- TKNO $16.53
- P/E Ratio
- MVBF $17.81
- TKNO N/A
- Revenue Growth
- MVBF N/A
- TKNO 11.40
- 52 Week Low
- MVBF $15.59
- TKNO $3.75
- 52 Week High
- MVBF $25.13
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- MVBF 48.53
- TKNO 49.37
- Support Level
- MVBF $23.12
- TKNO $4.39
- Resistance Level
- MVBF $23.96
- TKNO $4.97
- Average True Range (ATR)
- MVBF 0.59
- TKNO 0.42
- MACD
- MVBF -0.08
- TKNO 0.06
- Stochastic Oscillator
- MVBF 42.21
- TKNO 45.52
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.